4.7 Letter

Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls

Related references

Note: Only part of the references are listed.
Article Neurosciences

Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease

Hirosha Geekiyanage et al.

EXPERIMENTAL NEUROLOGY (2012)

Review Oncology

Circulating microRNAs: Association with disease and potential use as biomarkers

Glen Reid et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)

Article Biochemistry & Molecular Biology

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

Elena Minones-Moyano et al.

HUMAN MOLECULAR GENETICS (2011)

Article Biotechnology & Applied Microbiology

Identification of blood microRNAs associated to Parkinsonis disease

Regina Margis et al.

JOURNAL OF BIOTECHNOLOGY (2011)

Article Multidisciplinary Sciences

Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

Stephan Gehrke et al.

NATURE (2010)

Article Multidisciplinary Sciences

Repression of α-synuclein expression and toxicity by microRNA-7

Eunsung Junn et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Genetics & Heredity

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of α-synuclein

Gaofeng Wang et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2008)

Article Multidisciplinary Sciences

A microRNA feedback circuit in midbrain dopamine neurons

Jongpil Kim et al.

SCIENCE (2007)

Review Cell Biology

Stages in the development of Parkinson's disease-related pathology

H Braak et al.

CELL AND TISSUE RESEARCH (2004)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY